Micrologix, Strata Pharmaceuticals Inc. deal

By WIR Staff | Aug 9, 2004 | 7:00 AM GMT

MBI granted to Strata exclusive European and North American development and marketing rights to MBI-226, a topical antimicrobial

Read the full 180 word article

How to gain access

Continue reading with a
two-week free trial.